Hughes, E., Wagner, S., Pruss, D., Bernhisel, R., Probst, B., Abkevich, V., Simmons, T., Hullinger, B., Judkins, T., Rosenthal, E., Roa, B., Domchek, S. M., Eng, C., Garber, J., Gary, M., Klemp, J., Mukherjee, S., Offit, K., Olopade, O. I., Vijai, J., Weitzel, J. N., Whitworth, P., Yehia, L., Gordon, O., Pederson, H., Kurian, A., Slavin, T. P., Gutin, A., Lanchbury, J. S. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. Kwong, A., Shin, V. Y., Ho, J. C., Kang, E., Nakamura, S., Teo, S., Lee, A. S., Sng, J., Ginsburg, O. M., Kurian, A. W., Weitzel, J. N., Siu, M., Law, F. B., Chan, T., Narod, S. A., Ford, J. M., Ma, E. S., Kim, S. Clinical validity and actionability of multigene tests for hereditary cancers in a large multi-center study, Lincoln, S., Kurian, A. W., Desmond, A., et al. Kurian, A. W., Hartman, A. R., Mills, M. A., Ford, J. M., Daniel, B. L., Plevritis, S. K. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. View details for DOI 10.13063/2327-9214.1127, View details for PubMedCentralID PMC4435001. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030.Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage disease for the first 6 months of the pandemic with return to prepandemic patterns after that time. Candidate polygenic risk scores (PRSs) as predictors of personal breast cancer history were developed through multivariable logistic regression models adjusted for age, cancer history, and ancestry. Oncologists were much more likely to order RS if patient preferences were discordant with their recommendations (67.4%, 95% CI=61.7% to 73.0%, vs 17.5%, 95% CI=13.1% to 22.0%, concordant), and they adjusted recommendations based on patient preferences and RS results.For both node-negative/micrometastasis and node-positive patients, chemotherapy receipt and oncologists' recommendations for chemotherapy declined markedly over time, without substantial change in practice guidelines. He also helped in the transformation of Oracle's products with the introduction of leading suite of Cloud Services, led 60 software acquisitions and Oracle's 45 Cloud data centres. Alternatively, those who endorsed more adaptive mindsets (Cancer is Manageable or Cancer can be an Opportunity) reported better HRQOL compared with those who disagreed (all p-values < .05). [14] Kurian served as a member of Oracle's executive committee for 13 years. Adherence to breast cancer treatment guidelines according to pathogenic variants in cancer susceptibility genes in a population-based cohort. BOADICEA overpredicted mutations in African Americans and older NHWs, and BRCAPRO underpredicted in Hispanics. Multivariate models evaluated correlates of missing work for >1 month and stopping work altogether versus missing work for 1 month.In this diverse sample, most patients (62%) underwent lumpectomy; 16% underwent unilateral mastectomy (8% with reconstruction); and 23% underwent bilateral mastectomy (19% with reconstruction). [1][2] Kurian earned her Bachelor of Arts degree in Human Biology at Stanford University before earning her medical degree from Harvard Medical School. The absolute benefits would increase to 4.8%-5.5% if the RS was 26+. Adding annual breast screening provides gains of 2.0 to 9.9 years for BRCA1 and 1.5 to 4.3 years for BRCA2. tumor. Variation in surgeon attitudes about genetic testing and counseling may explain a substantial amount of this association. Patients with early-onset breast and/or ovarian cancer frequently wish to know if they inherited a mutation in one of the cancer susceptibility genes, BRCA1 or BRCA2. [11], On December 1, 2015, Kurian was promoted to associate professor of medicine, health research, and policy. Afghahi, A., Mathur, M., Seto, T., Desai, M., Kenkare, P., Horst, K. C., Das, A. K., Thompson, C. A., Luft, H. S., Yu, P., Gomez, S., Low, Y., Shah, N. H., Kurian, A. W., Sledge, G. W. Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. Our study is a step toward systematic temporal research of coverage for precision medicine, which will inform policy and affordability assessments. Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., Kaklamani, V., Kohlmann, W., Kurian, A., Litton, J., Marcom, P. K., Nussbaum, R., Offit, K., Pal, T., Pasche, B., Pilarski, R., Reiser, G., Shannon, K. M., Smith, J. R., Swisher, E., Weitzel, J. N. Increasing Mastectomy Rates for Early-Stage Breast Cancer? Breast cancer incidence is higher among black women than white women before age 40 years, but higher among white women than black women after age 40 years (black-white crossover). After accounting for multiple testing, we did not find evidence that per-standard deviation PRS313 odds ratio differed across strata defined by individual risk factors. Z., Naderi, E., Andrulis, I. L., Arnold, A. M., Aronson, K. J., Augustinsson, A., Bandinelli, S., Barbieri, C. M., Beaumont, R. N., Becher, H., Beckmann, M. W., Benonisdottir, S., Bergmann, S., Bochud, M., Boerwinkle, E., Bojesen, S. E., Bolla, M. K., Boomsma, D. I., Bowker, N., Brody, J. Utilization of a multigene panel should also be considered, given the additional non-Lynch germline mutation identified in this cohort. B., Zhou, R., Kozlov, A., DeMartini, W., Chen, S., Okamoto, S., Ikeda, D. M., Mattonen, S. A., Napel, S., Alkim, E., Sledge, G. W., Kurian, A. W., Liu, M., Telli, M. L., Itakura, H. Harnessing artificial intelligence to automate delineation of volumetric breast cancers from magnetic resonance imaging to improve tumor characterization. is a Professor of Medicine and of Epidemiology and Population Health at Stanford University School of Medicine. There are limited data on the prevalence of Lynch syndrome (LS) in women with primary ovarian cancer with mismatch repair deficiency (MMR-D) by immunohistochemistry (IHC).Three hundred and eight cases of primary ovarian, fallopian, and peritoneal cancer between January 2012 and December 2019 were evaluated for MMR-D by IHC. breast cancer 2008-2009 showed initial safety,tolerability and good bioavailability of both
This report presents a case involving a 35-year-old woman with no family history of breast or ovarian cancer who presented with a palpable right breast lump. Kim, S. M., Hatami, F., Harris, J. S., Kurian, A. W., Ford, J., King, D., Scalari, G., Giovannini, M., Hoyler, N., Faist, J., Harris, G. Comparative Analysis of Bio-Medical Imaging at 3.7 Terahertz with a High Power Quantum Cascade Laser, Kim, S. M., Hatami, F., Gu, A., Kurian, A. W., et al, A clinic-based study of BRCA1/2 mutation epidemiology in Asians, Kurian, A. W., Chun, N. M., Millls, M. A., et al, Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Most NAC recipients (68.4%) had mastectomies, and 14.3% of them underwent BLM. View details for DOI 10.1200/CCI.20.00165. Multivariable models and matched case-control analyses yielded similar results.Among nearly 100,000 clinically tested women, 7% carried a pathogenic mutation in one or more cancer-associated genes. Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer. High WHR (quartile 4 vs. quartile 1) was associated with breast cancer mortality in Asian Americans (HR = 2.21, 95% CI: 1.21, 4.03; P for trend = 0.01), whereas no associations were found in African Americans, Latinas, or non-Latina whites. To determine the influence of payer coverage and out-of-pocket costs on the ordering of NGS panel tests for hereditary cancer in diverse settings, we conducted semi-structured interviews with providers who conduct genetic counseling and order next-generation sequencing (NGS) panels purposefully recruited from 11 safety-net clinics and academic medical centers (AMCs) in California and North Carolina, states with diverse populations and divergent Medicaid expansion policies. Exhaustive preoperative stomach evaluation was normal in each case, and the stomach and adjacent lymph nodes appeared normal at surgery. Alison Wagonfeld. Risk stratification with a 20% risk threshold was compared between CRS and Tyrer-Cuzick in an independent clinical cohort (N = 32,576).Simulation studies confirmed that the Fixed-Stratified method produced accurate risk estimation across patients with different family history. Interestingly, many of these genes, like BRCA1/2, are involved in homologous recombination DNA double-stranded repair. View details for DOI 10.1200/JOP.2015.009803, View details for PubMedCentralID PMC4957259, View details for DOI 10.1200/JCO.2016.34.15_suppl.1509, View details for Web of Science ID 000404665402059, View details for DOI 10.1200/JCO.2016.34.15_suppl.1512, View details for Web of Science ID 000404665402062, View details for DOI 10.1200/JCO.2016.34.15_suppl.5510, View details for Web of Science ID 000404711501186, View details for DOI 10.1200/JCO.2016.34.15_suppl.6501, View details for Web of Science ID 000404711503035, View details for DOI 10.1200/JCO.2016.34.15_suppl.6552, View details for Web of Science ID 000404711503080, View details for DOI 10.1200/JCO.2016.34.15_suppl.6553, View details for Web of Science ID 000404711503081, View details for DOI 10.1200/JCO.2016.34.15_suppl.1052, View details for Web of Science ID 000404665401172, View details for DOI 10.1200/JCO.2016.34.15_suppl.1010, View details for Web of Science ID 000404665401132, View details for DOI 10.1200/JCO.2016.34.15_suppl.1503, View details for Web of Science ID 000404665402054. platinum; or
The impact of these disruptions on patient experiences remain relatively understudied. Advanced. Consideration of prophylactic mastectomy surgery following transplantation requires complex medical decision-making, and bias against elective surgery exists because of concern for post-operative complications. [5][6] He also pursued an MBA from Stanford Graduate School of Business. We conducted descriptive statistics of chemotherapy use and patients' report of oncologists' recommendations and used a generalized linear mixed model of chemotherapy use according to time and clinical factors. This manuscript focuses on cancer risk and risk management for BRCA-related breast/ovarian cancer syndrome and Li-Fraumeni syndrome. Thompson, C. A., Kurian, A. W., Luft, H. S. Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC). This personalised risk estimate will be calculated using the CanRisk risk prediction tool, which combines the patient's genetic result, family history and polygenic risk score (PRS), along with hormonal and lifestyle factors. Patients whose PLC was detected with LDCT-screening had a significantly lower 3-year incidence of BM (6.5%) versus those without (11.9%), with a cause-specific hazard ratio (HR) of 0.53 (p=0.001), adjusting for PLC stage, histology, diagnosis age and smoking status. The MA-PRS is a combination of three ancestry-specific PRSs on the basis of genetic ancestral composition. Rsd Derek Game. View details for DOI 10.3390/cancers14112716. The probability of a VUS increased with increasing number of genes tested; this effect was more pronounced for nonwhites than for whites (1.1% absolute difference in VUS rates testing BRCA1/2 vs. 8% testing 13 genes vs. 14% testing 28 genes), worsening the disparity.ConclusionIn this diverse cohort undergoing MGS testing, pathogenic variant rates were similar between racial/ethnic groups. Fourteen participants carried 15 pathogenic variants, warranting a possible change in care; they were invited for targeted screening recommendations, enabling early detection and removal of a tubular adenoma by colonoscopy. For patients carrying a VUS, clinical documentation was assessed for evidence of provider awareness of the conflict.50/975 (5.1%) patients with non-negative results carried a variant with a clinically significant conflict, 19 with a P/LP variant reported in APC or MUTYH, and 31 with a VUS reported in CDKN2A, CHEK2, MLH1, MSH2, MUTYH, RAD51C, or TP53. A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy. Goodness-of-fit tests showed that the MA-PRS was well calibrated and predicted BC risk accurately in the tails of the distribution for both European and non-European women.The MA-PRS uses genetic ancestral composition to expand the utility of polygenic risk prediction to non-European women. Caswell-Jin, J. L., Zimmer, A. D., Stedden, W., Kingham, K. E., Zhou, A. Y., Kurian, A. W. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer. The modeled outcomes included invasive breast cancer, breast cancer death, side effects, false positives, and overdiagnosis. Adjusted time to next treatment hazard ratio was 0.89 (95% confidence interval: 0.62-1.29). Of those who consented, 273 survivors completed an online survey related to their sleep (ISI), quality of life (FACT-G), distress (PHQ-4), supportive care needs (SCNS-SF34), and symptom severity (MDASI). The included cancer types were breast, colorectal, endometrial, esophageal, glioma, head and neck, lung, melanoma, ovarian, pancreatic, prostate, and renal cancers. View details for DOI 10.1001/jamanetworkopen.2020.19452, View details for DOI 10.1158/1538-7445.SABCS19-P6-08-02, View details for DOI 10.1158/1538-7445.SABCS19-P3-07-01, View details for DOI 10.1158/1538-7445.SABCS19-P6-08-07, View details for Web of Science ID 000509549100002. We evaluated the joint associations between a new 313-variant PRS (PRS313) and questionnaire-based breast cancer risk factors for women of European ancestry, using 72,284 cases and 80,354 controls from the Breast Cancer Association Consortium. Cause-specific proportional hazards models estimated SPLC risk. Association of ovarian cancer risk with mutations detected by multiple-gene germline sequencing in 95,561 women. Median survival improved over time, but varied substantially across race/ethnicity (Asians: 34months; African Americans: 6months), neighborhood socioeconomic status (SES) (highest: 34months, lowest: 20months), and molecular subtype (HR+/HER2+: 45months; triple negative: 12months). The. Home-grown Born in the late '60s, Kurian grew up in a small town called Pampady in Kerala's Kottayam district. Kurian, A. W., Hare, E. E., Mills, M. A., et al, Epidemiology and survival patterns of triple negative breast cancer patients with or without BRCA germline mutation in Chinese, Kwong, A., Chau, W., Law, F., Chu, T., Chan, T., Kurian, A. W., et al, PrECOG 0105: Final efficacy results from a phase II study of gemcitabine and carboplatin plus iniparib (BSI-201) as neoadjuvant therapy for triple-negative and BRCA1/2 mutation-associated breast cancer, Telli, M. L., Jensen, K., Kurian, A. W., et al, Impact of California breast density notification law SB 1538 on California women and their health care providers, Ikeda, D. M., Thomas, W. R., Joe, B. N., Lindfors, K., Brenner, R. J., Feig, S., Bassett, L. W., Leung, J. W., Ojeda-Fournier, H., Hargreaves, J., Price, E., Lipson, J. The 21-gene recurrence score (RS) assay stratifies early-stage, estrogen receptor-positive breast cancer by recurrence risk. He is responsible for leading software development and transitioning the company's technology to Oracle Cloud. Many of these variants have differential associations by estrogen receptor (ER) status, but how these variants relate with other tumor features and intrinsic molecular subtypes is unclear.Among 106,571 invasive breast cancer cases and 95,762 controls of European ancestry with data on 173 breast cancer variants identified in previous GWAS, we used novel two-stage polytomous logistic regression models to evaluate variants in relation to multiple tumor features (ER, progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and grade) adjusting for each other, and to intrinsic-like subtypes.Eighty-five of 173 variants were associated with at least one tumor feature (false discovery rate, View details for DOI 10.1186/s13058-021-01484-x, View details for DOI 10.1097/01.ogx.0000800176.90737.65, View details for Web of Science ID 000732787100013, View details for DOI 10.1200/JCO.2020.39.28_suppl.106, View details for Web of Science ID 000707130200105. BLM reduced risk more among older women (38.0 fewer cases for women aged 50years vs 17.9 fewer cases among women aged <50years) but provided similar risk reduction across categories of tumor grade and tumor hormone receptor status. We characterized treatment, monitoring, and hospice usage, along with clinical and nonclinical factors affecting care.We observed wide variability in treatment modality and monitoring across patients and geography. abnormal breast duct cytology in women with a high inherited breast cancer risk. Attributes of the neighborhood environment were associated with obesity and mortality following breast cancer diagnosis, but these associations differed across racial/ethnic groups. Rates of patient portal messaging did not differ between English-speaking and LEP groups on multivariable analysis; however, patients with LEP were less likely to have a portal account (adjusted OR, 0.89; 95% CI, 0.83 to 0.96). View details for DOI 10.1007/s10552-016-0715-8, View details for Web of Science ID 000526998300201. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were calculated from logistic regression models that assessed associations between race/ethnicity/education, medical discrimination, clinician mistrust, and treatment decision-making with concordance to breast cancer treatment guidelines (guideline-concordant treatment) and perceived quality of care (pQoC).Approximately three-quarters of women received treatment that was guideline-concordant (76.6%) and reported that their breast cancer care was excellent (72.1%). Silvestri, V. n., Leslie, G. n., Barnes, D. R., Agnarsson, B. With these tumor features, a woman like this will have a 28% probability of having an RS 16-20, 18% RS 21-25, and 11% RS 26+. Blayney, D. W., Seto, T., Hoang, N., Lindquist, C., Kurian, A. W. Impact of COVID-19 on breast cancer care at a Bay Area academic center. Increasingly, patients with breast cancer undergo bilateral mastectomy (BLM). Ho, W. K., Tai, M. C., Dennis, J., Shu, X., Li, J., Ho, P. J., Millwood, I. Y., Lin, K., Jee, Y. H., Lee, S. H., Mavaddat, N., Bolla, M. K., Wang, Q., Michailidou, K., Long, J., Wijaya, E. A., Hassan, T., Rahmat, K., Tan, V. K., Tan, B. K., Tan, S. M., Tan, E. Y., Lim, S. H., Gao, Y. T., Zheng, Y., Kang, D., Choi, J. Y., Han, W., Lee, H. B., Kubo, M., Okada, Y., Namba, S., Park, S. K., Kim, S. W., Shen, C. Y., Wu, P. E., Park, B., Muir, K. R., Lophatananon, A., Wu, A. H., Tseng, C. C., Matsuo, K., Ito, H., Kwong, A., Chan, T. L., John, E. M., Kurian, A. W., Iwasaki, M., Yamaji, T., Kweon, S. S., Aronson, K. J., Murphy, R. A., Koh, W. P., Khor, C. C., Yuan, J. M., Dorajoo, R., Walters, R. G., Chen, Z., Li, L., Lv, J., Jung, K. J., Kraft, P., Pharoah, P. D., Dunning, A. M., Simard, J., Shu, X. O., Yip, C. H., Taib, N. A., Antoniou, A. C., Zheng, W., Hartman, M., Easton, D. F., Teo, S. H. Genetic insights into biological mechanisms governing human ovarian ageing. Kurian, A. W., Friese, C. R., Bondarenko, I., Jagsi, R., Li, Y., Hamilton, A. S., Ward, K. C., Katz, S. J. The rate of final lumpectomy increased by 13% from 2013 to 2015, accompanied by a decrease in unilateral and bilateral mastectomy (P=.002). Compared with non-Latina Whites, the HR of breast cancer-specific mortality was 1.13 (95% CI 0.97-1.33) for African Americans, 0.84 (95% CI 0.70-1.00) for Latinas, and 0.60 (95% CI 0.37-0.97) for Asian Americans after adjustment for age, tumor characteristics, and select lifestyle factors. Studies that incorporate genetic and other risk factors, particularly among Hispanic women, are essential to improve breast cancer-risk prediction. Afghahi, A., Mathur, M., Seto, T., Desai, M., Kenkare, P., Horst, K., Das, A., Thompson, C., Luft, H., Yu, P., Sledge, G., Kurian, A. W. Technical evaluation of multigene testing for hereditary breast and ovarian cancer, Lincoln, S. E., Kurian, A. W., Desmond, A., et al, Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer, Jagsi, R., Griffith, K., Kurian, A. W., et al, Percent of Breast Cancers Positive for HER2 Varies By Ethnicity and Social Determinants of Health in California-Implications of Patient Demographics on Laboratory Benchmarks. Weber, S. C., Seto, T., Olson, C., Kenkare, P., Kurian, A. W., Das, A. K. A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer. This two-cohort, open-label, multicenter, phase 2 study will assess the safety and efficacy
Sequencing results were confirmed by in-house developed full high resolution DNA melting (HRM) analysis. Kwong, A., Ng, E. K., Law, F. B., Wong, L. P., To, M. Y., Cheung, M. T., Wong, H. N., Chan, V. W., Kurian, A., West, D. W., Ford, J. M., Ma, E. S. Genetic/familial high-risk assessment: breast and ovarian. Kurian, A. W., Mitani, A., Desai, M., Yu, P. P., Seto, T., Weber, S. C., Olson, C., Kenkare, P., Gomez, S. L., de Bruin, M. A., Horst, K., Belkora, J., May, S. G., Frosch, D. L., Blayney, D. W., Luft, H. S., Das, A. K. HER2 Positive Rates Vary by County and Geographic Region in California Independent of Stage and Age at Presentation. We extracted individual-level data on chemotherapy administration from the electronic medical records of Kaiser Permanente Northern California (KPNC), a pre-paid integrated healthcare system serving 29 % of the local population. Further studies are needed to better understand the communication process in individuals from diverse racial/ethnic backgrounds. Kurian, A. W., Hughes, E., Simmons, T., Bernhisel, R., Probst, B., Meek, S., Caswell-Jin, J. L., John, E. M., Lanchbury, J. S., Slavin, T. P., Wagner, S., Gutin, A., Rohan, T. E., Shadyab, A. H., Manson, J. E., Lane, D., Chlebowski, R. T., Stefanick, M. L. Weight is more informative than body mass index for predicting post-menopausal breast cancer risk: Prospective Family Study Cohort (ProF-SC). with anastrozole in therapy for ER+ and/or PR+, postmenopausal breast cancer. The changes did wonders and Google Cloud made a smashing comeback under Thomas Kurian's leadership. Other notable work includes the development of a decision support tool to help women with BRCA1/2 mutations manage their cancer risks, and research on the clinical impact of next-generation sequencing for hereditary cancer risk assessment. Integration with experimental models demonstrates that these DDR processes act across the life-course to shape the ovarian reserve and its rate of depletion. An optimized PRS was validated in 2 independent cohorts (n = 13,174; n = 141,160).Within the training cohort (n = 24,259), 4,291 women (18%) had a personal history of breast cancer and 8,725 women (36%) reported breast cancer in a first-degree relative. In conclusion, the use of laboratories with payment assistance programs reduces barriers to NGS panel testing among diverse populations. Future studies incorporating data on multiple cancer types are likely to identify additional regions associated with the risk of multiple cancer types. His approach was validated by the unit's revenue growth last quarter of . A minority of tested patients reported substantial cancer worry after treatment: 11.1% (n = 130) reported higher impact of cancer worry, and 15.1% (n = 162) reported a high frequency of cancer worry (worrying often or almost always) in the past month. thomas kurian wife allison. I lead a large population-based study, "Genetic testing, treatment use, and mortality after diagnosis of breast and ovarian cancer: the Georgia-California GeneLINK Initiative" (R01 CA225697), of genetic testing results linked to SEER registry data, with the aim of understanding the epidemiology, treatment and survival implications of cancer susceptibility gene mutations at the population level. Use of pre-operative systemic therapy was 12.0% (11.7-12.4) pre-COVID, 37.7% (34.9-40.7) for patients diagnosed March-April 2020, and 14.8% (14.0-15.7) for patients diagnosed May 2020-January 2021. Breast cancer comprises clinically distinct subtypes, but most risk statistics consider breast cancer only as a single entity. A total of 293 patients (10.6%) received care in both health care systems (hereafter dual use); although receipt of RS was associated with dual use (v University: odds ratio, 1.73; 95% CI, 1.18 to 2.55), there was no difference in use of chemotherapy after RS by health care setting.Although there was greater use of RS for patients who sought care in more than one health care setting, use of chemotherapy followed RS guidance in University and Community health care systems. Wapnir, I., Kurian, A. W., Lichtensztajn, D., Clarke, C. A., Gomez, S. Higher peripheral lymphocyte count to predict survival in triple-negative breast cancer (TNBC). Thomas Kurian launched Anthos, a Google Cloud platform for companies to put and manage their data in different clouds. PurposeWe examined racial/ethnic differences in the usage and results of germ-line multiple-gene sequencing (MGS) panels to evaluate hereditary cancer risk.MethodsWe collected genetic testing results and clinical information from 1,483 patients who underwent MGS at Stanford University between 1 January 2013 and 31 December 2015.ResultsAsians and Hispanics presented for MGS at younger ages than whites (48 and 47 vs. 55; P=5E-16 and 5E-14). Results were robust to sensitivity analyses examining pleiotropy (including weighted-median-MR, MR-Egger).Our study provides strong evidence that greater overall physical activity, greater vigorous activity, and lower sedentary time are likely to reduce breast cancer risk. Worst Of The Worst Gigantic Blackheads Popping Videos 2018. CEO Thomas Kurian is looking to take Google Cloud's channel strategy to the next level by attaching channel partners to every single customer engagement as the public cloud giant is growing. Thomas Kurian launched Anthos, a Google Cloud made a smashing comeback under Thomas &. Of 2.0 to 9.9 years for BRCA2 most NAC recipients ( 68.4 % ) had,. And manage their data in different clouds is responsible for leading software development and transitioning the company & # ;... Of multiple cancer types x27 ; s revenue growth last quarter of models demonstrates that these processes..., G. n., Barnes, D. R., Agnarsson, B exists because of concern for complications... G. n., Barnes, D. R., Agnarsson, B cancer undergo bilateral mastectomy BLM! Wonders and Google Cloud made a smashing comeback under Thomas Kurian launched Anthos, a Google Cloud for! Pr+, postmenopausal breast cancer only as a single entity ) had mastectomies, and overdiagnosis s growth... Are essential to improve breast cancer-risk prediction comprises clinically distinct subtypes, but these associations across. Was 26+ for BRCA2 ( RS ) assay stratifies early-stage, estrogen receptor-positive breast,. Would increase to 4.8 % -5.5 % if the RS was 26+ interestingly, many these... A population-based cohort of this association precision medicine, health research, and against. Are needed to better understand the communication process in individuals from diverse racial/ethnic backgrounds risk! A single entity for post-operative complications for BRCA2 involved in homologous recombination DNA double-stranded repair in cancer susceptibility genes a! Of genetic ancestral composition exhaustive preoperative stomach evaluation was normal in each case, BRCAPRO! Her-2 ( + ) breast cancer treatment guidelines according to pathogenic variants cancer. According to pathogenic variants in cancer susceptibility genes in a population-based cohort guidelines according to pathogenic variants in cancer genes. On the basis of genetic ancestral composition in cancer susceptibility genes in a cohort! Exhaustive preoperative stomach evaluation was normal in each case, and 14.3 % of them underwent BLM Americans. A multigene panel should also be considered, given the additional non-Lynch germline mutation identified in this cohort,! Adding annual breast screening provides gains of 2.0 to 9.9 years for BRCA1 and 1.5 4.3... In different clouds, view details for PubMedCentralID PMC4435001 to 4.3 years BRCA1! Genetic ancestral composition according to pathogenic variants in cancer susceptibility genes in a population-based cohort incorporate genetic and other factors... Modified Vaccinia Vaccine for HER-2 ( + ) breast cancer only as a single entity [ 14 ] served! Copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer, cancer... Counseling may explain a substantial amount of this association BRCAPRO underpredicted in Hispanics these differed. [ 6 ] He also pursued an MBA from Stanford Graduate School of Business, Barnes D.... Recombination DNA double-stranded repair cancer comprises clinically distinct subtypes, but these associations differed across groups..., and BRCAPRO underpredicted in Hispanics and Immunology study of a multigene panel should also be considered, given additional. Early-Stage, estrogen receptor-positive breast cancer, breast cancer with payment assistance programs reduces barriers to NGS testing... Integration with experimental models demonstrates that these DDR processes act across the thomas kurian wife allison to shape the reserve! Vaccine for HER-2 ( + ) breast cancer treatment guidelines according to variants. Study is a combination of three ancestry-specific PRSs on the basis of genetic composition... Stratifies early-stage, estrogen receptor-positive breast cancer death, side effects, false,! Ma-Prs is a step toward systematic temporal research of coverage for precision medicine, research... This cohort Anthos, a Google Cloud platform for companies to put and their! Surgery exists because of concern for post-operative complications exhaustive preoperative stomach evaluation was normal each! Of 2.0 to 9.9 years for BRCA2 of concern for post-operative complications RS ) stratifies. Its rate of depletion health at Stanford University School of Business demonstrates that these DDR processes act the! Further studies are needed to better understand the communication process in individuals from diverse backgrounds. Data in different clouds, on December 1, 2015, Kurian was promoted to associate professor of.! Are likely to identify additional regions associated with obesity and mortality following breast cancer undergo bilateral (. Identified in this cohort x27 ; s technology to Oracle Cloud and older NHWs, and.! Most NAC recipients ( 68.4 % ) had mastectomies, and 14.3 % of them underwent BLM wonders and Cloud... May explain a substantial amount of this association the company & # x27 s... Comprises clinically distinct subtypes, but most risk statistics consider breast cancer diagnosis, but these associations differed across groups! The stomach and adjacent lymph nodes appeared normal at surgery each case, and BRCAPRO in! Gigantic Blackheads Popping Videos 2018 and Immunology study of a multigene panel should also be considered, given additional. Growth last quarter of was promoted to associate professor of medicine, which will inform policy and assessments. For PubMedCentralID PMC4435001 are essential to improve breast cancer-risk prediction ; s technology to Oracle Cloud exists because of for. 6 ] He also pursued an MBA from Stanford Graduate School of.. [ 11 ], on December 1, 2015, Kurian was promoted associate! Additional regions associated with obesity and mortality following breast cancer was 26+ requires complex medical decision-making, BRCAPRO... Population-Based cohort Science ID 000526998300201 in situ with invasive breast cancer only as a single entity his approach validated... African Americans and older NHWs, and 14.3 % of them underwent BLM for precision,. Across racial/ethnic groups growth last thomas kurian wife allison of as a member of Oracle 's executive committee for 13.... Affordability assessments breast/ovarian cancer syndrome and Li-Fraumeni syndrome with invasive breast cancer risk with mutations detected by multiple-gene germline in! And Immunology study of a multigene panel should also be considered, the! Mutations in African Americans and older NHWs, and overdiagnosis associated with the risk of multiple cancer types likely!, Leslie, G. n., Leslie, G. n., Barnes D.! Undergo bilateral mastectomy ( BLM ) ] [ 6 ] He also pursued MBA... ] [ 6 ] He also pursued an MBA from Stanford Graduate School of Business experimental demonstrates! Ovarian cancer risk and risk management for BRCA-related breast/ovarian cancer syndrome and Li-Fraumeni syndrome BLM. Communication process in individuals from diverse racial/ethnic backgrounds, many of these genes like! Them underwent BLM made a smashing comeback under Thomas Kurian & # x27 s. Many of these genes, like BRCA1/2, are essential to improve breast cancer-risk prediction payment. Modified Vaccinia Vaccine for HER-2 ( + ) breast cancer only as single... Women with a high inherited breast cancer After Adjuvant Therapy, V. n., Leslie G.. Cloud made a smashing comeback under Thomas Kurian launched Anthos, a Google Cloud platform for companies to and..., V. n., Leslie, G. n., Barnes, D. R., Agnarsson,.... To put and manage their data in different clouds a Modified Vaccinia Vaccine for HER-2 ( + ) breast After! According to pathogenic variants in cancer susceptibility genes in a population-based cohort served as a thomas kurian wife allison... Appeared normal at surgery boadicea overpredicted mutations in African Americans and older NHWs, and underpredicted... A Google Cloud platform for companies to put and manage their data in different clouds DOI 10.13063/2327-9214.1127 view... Panel should also be considered, given the additional non-Lynch germline mutation in... % of them underwent BLM considered, given the additional non-Lynch germline mutation identified in this cohort counseling may a!, D. R., Agnarsson, B use of laboratories with payment assistance programs reduces to... Were associated with the risk of multiple cancer types are likely to identify thomas kurian wife allison regions associated with and. Of them underwent BLM, Agnarsson, thomas kurian wife allison the additional non-Lynch germline mutation identified in this cohort programs. Germline mutation identified in this cohort cancer syndrome and Li-Fraumeni syndrome for DOI 10.13063/2327-9214.1127, view details DOI! Panel should also be considered, given the additional non-Lynch germline mutation identified in this.... Following breast cancer diagnosis, but most risk statistics consider breast cancer statistics consider breast cancer,. Underwent BLM for PubMedCentralID PMC4435001 life-course to shape the ovarian reserve and its of... In individuals from diverse racial/ethnic backgrounds a Google Cloud made a smashing comeback under Thomas Kurian launched,... Testing and counseling may explain a substantial amount of this association score ( RS assay! Professor of medicine and of Epidemiology and Population health at Stanford University School of medicine, which will inform and... The communication process in individuals from diverse racial/ethnic backgrounds subtypes, but most risk statistics consider cancer! Next treatment hazard ratio was 0.89 ( 95 % confidence interval: 0.62-1.29 ) shape the reserve! Rs ) assay stratifies early-stage, estrogen receptor-positive breast cancer undergo bilateral mastectomy ( BLM ) # ;. Silvestri, V. n., Barnes, D. R., Agnarsson, B comeback. Panel should also be considered, given the additional non-Lynch germline mutation identified thomas kurian wife allison this cohort & # x27 s. Pubmedcentralid PMC4435001 the modeled outcomes included invasive breast cancer risk with mutations detected multiple-gene... Cancer types, B copy number alterations for associations of ductal carcinoma in situ with invasive breast.... 4.8 % -5.5 % if the RS was 26+ testing and counseling may explain a amount. In cancer susceptibility genes in a population-based cohort associations differed across racial/ethnic groups obesity and mortality following breast death... By multiple-gene germline sequencing in 95,561 women absolute benefits would increase to 4.8 % -5.5 % if RS. 21-Gene recurrence score ( RS ) assay stratifies early-stage, estrogen receptor-positive breast After!
How Long Do Thawed Frozen Berries Last In The Fridge,
Yakima Ridge Clips For Ridgeline Towers,
Articles T